You just read:

Nektar Presents New Preclinical Data for NKTR-358, a First-in-Class Regulatory T Cell Stimulator, at 13th World Congress of Inflammation in London

News provided by

Nektar Therapeutics

Jul 10, 2017, 09:00 ET